scanX
Home
Sigachi Industries

Sigachi Industries

48.09
-1.68
(-3.38%)
Market Cap (₹ Cr.)
₹1,659
52 Week High
95.90
Book Value
₹13
52 Week Low
43.35
PE Ratio
25.12
PB Ratio
3.52
PE for Sector
37.21
PB for Sector
3.95
ROE
16.22 %
ROCE
15.31 %
Dividend Yield
0.20 %
EPS
₹1.81
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Indian - Bulk Drugs & Formln
Live Chart
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
33.02 %
Net Income Growth
31.54 %
Cash Flow Change
-55.58 %
ROE
-19.96 %
ROCE
-31.99 %
EBITDA Margin (Avg.)
1.55 %

Financial Results

Quarterly Financials
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Revenue
48
50
54
58
67
73
73
79
67
78
79
80
79
91
82
124
Expenses
39
38
42
45
54
58
58
63
52
62
63
66
61
69
64
91
EBITDA
9
11
12
13
13
15
16
17
15
16
17
14
18
22
18
33
Operating Profit %
18 %
22 %
22 %
22 %
18 %
19 %
20 %
19 %
21 %
18 %
20 %
17 %
21 %
18 %
20 %
16 %
Depreciation
1
1
1
1
1
1
1
2
2
2
2
2
2
3
2
3
Interest
0
0
0
0
0
0
0
1
1
1
1
2
2
2
3
2
Profit Before Tax
8
11
11
12
12
14
14
13
12
12
14
11
14
17
13
28
Tax
1
2
2
3
2
3
3
3
2
2
3
2
3
4
3
3
Net Profit
7
9
9
9
9
10
11
12
9
9
10
8
11
12
9
22
EPS in ₹
2.97
3.76
3.85
4.09
3.76
4.02
3.54
3.88
3.03
0.31
3.30
2.72
0.34
0.37
0.28
0.66
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
56
60
71
91
109
134
284
369
609
Fixed Assets
23
23
26
29
32
38
53
122
139
Current Assets
32
35
43
58
72
87
177
171
248
Capital Work in Progress
0
1
1
2
3
4
10
35
91
Investments
0
0
0
0
0
0
0
2
102
Other Assets
33
36
45
60
74
92
221
210
276
Total Liabilities
38
40
44
44
43
39
57
103
198
Current Liabilities
31
34
38
40
37
32
50
73
141
Non Current Liabilities
8
6
6
4
5
7
8
31
57
Total Equity
18
20
27
47
67
95
227
266
410
Reserve & Surplus
15
17
24
43
59
87
196
235
377
Share Capital
3
3
3
3
8
8
31
31
33
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
1
-1
-0
8
8
51
-39
20
Investing Activities
-2
-4
-6
-7
-11
-63
-93
-158
Operating Activities
9
7
15
12
28
5
28
15
Financing Activities
-6
-4
-9
3
-9
108
26
163
Above figures are in Rs. Crores

Share Holding

% Holding
Nov 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Oct 2023
Dec 2023
Mar 2024
Jun 2024
Aug 2024
Sept 2024
Promoter
48.46 %
48.48 %
48.48 %
48.48 %
48.48 %
48.49 %
48.49 %
48.49 %
48.49 %
48.49 %
46.08 %
45.43 %
45.43 %
45.43 %
44.71 %
FIIs
1.28 %
1.42 %
0.23 %
0.11 %
0.08 %
0.05 %
0.09 %
0.05 %
0.95 %
0.96 %
1.76 %
2.06 %
1.56 %
1.60 %
1.58 %
DIIs
9.43 %
4.70 %
2.92 %
2.60 %
0.01 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
40.84 %
45.41 %
48.37 %
48.82 %
51.43 %
51.46 %
51.43 %
51.46 %
50.56 %
50.55 %
52.16 %
52.51 %
53.01 %
52.97 %
53.71 %

Dividend History

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
Sun Pharmaceutical
1,764.05 4,25,929.94 38.00 49,887.17 12.06 9,648 27.35 40.28
Cipla
1,456.00 1,18,825.56 25.74 26,520.66 14.17 4,155 12.95 38.47
Mankind Pharma
2,534.35 1,02,885.42 48.65 10,615.63 19.57 1,942 28.89 46.80
Dr Reddys Laboratories
1,193.90 1,01,290.13 18.97 28,905.40 12.36 5,578 -9.47 32.64
Zydus Life Science
940.70 95,280.30 22.27 19,831.50 13.82 3,831 14.57 32.02
Lupin
2,038.25 92,929.19 35.38 20,141.50 19.94 1,936 73.52 37.01
Aurobindo Pharma
1,221.10 73,119.28 20.05 29,559.25 17.55 3,169 8.65 20.74
Alkem Laboratories
5,555.15 66,062.65 30.38 12,978.42 9.84 1,811 14.16 35.74
Glenmark Pharmaceuticals
1,461.85 42,112.35 - 12,653.09 6.58 -1,831 675.84 30.08
IPCA Laboratories
1,567.00 39,910.21 59.43 7,829.81 22.92 529 80.05 52.38

Corporate Action

Technical Indicators

RSI(14)
Neutral
46.31
ATR(14)
Less Volatile
2.21
STOCH(9,6)
Neutral
53.27
STOCH RSI(14)
Neutral
73.14
MACD(12,26)
Bullish
0.34
ADX(14)
Weak Trend
24.08
UO(9)
Bearish
42.97
ROC(12)
Uptrend But Slowing Down
1.65
WillR(14)
Neutral
-41.41
Bearish
4
Neutral
4
Bullish
1
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Intraday Screeners
Price & Volume Screeners
Technical Screeners
Candlestick Screeners
Fundamental Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2024 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Corporate Office: A-302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai – 400066, Maharashtra, India. Land Line: 022-43116666.